Green Brook, NJ, United States of America

Christopher Alan Willoughby

USPTO Granted Patents = 8 

Average Co-Inventor Count = 8.3

ph-index = 5

Forward Citations = 107(Granted Patents)


Location History:

  • Edison, NJ (US) (2001)
  • Clark, NJ (US) (2000 - 2002)
  • Greenbrook, NJ (US) (2003)

Company Filing History:


Years Active: 2000-2003

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Inventor Spotlight: Christopher Alan Willoughby

Introduction:

Christopher Alan Willoughby, a prolific inventor based in Green Brook, NJ, has made significant contributions to the field of patent innovations. With a total of 8 patents to his name, his work demonstrates a deep understanding of pharmaceuticals and chemistry.

Latest Patents:

Two of Willoughby's latest patents include "Pyrrolidine modulators of CCR5 chemokine receptor activity" and "2-aryl indole derivative as antagonists of tachykinins." These cutting-edge inventions showcase his ability to develop novel solutions in the medical and pharmaceutical sectors.

Career Highlights:

Having worked at prestigious companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation, Willoughby has honed his skills alongside industry leaders. His innovative spirit and dedication to research have led to the successful filing of multiple patents over the years.

Collaborations:

Throughout his career, Willoughby has collaborated with esteemed coworkers such as Sander G Mills and Jeffrey John Hale. These partnerships have not only enriched his own knowledge but have also paved the way for groundbreaking inventions in the pharmaceutical industry.

Conclusion:

In conclusion, Christopher Alan Willoughby stands as a beacon of innovation in the field of patent inventions. His extensive portfolio of patents, coupled with his collaborative efforts and industry experience, solidify his reputation as a trailblazer in the world of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…